Metraipolis › archive › dc_5851a03ecee4

Tumor-Treating Fields Plus Temozolomide Versus Temozolomide Alone in Newly Diagnosed Glioblastoma: A Systematic Review and Bayesian Meta-Analysis with… — Europe PMC PMID:42352481

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42352481
DOI
10.3390/cancers18121947
License (as archived)
solo-consultazione
Archived
2026-10-19T09:25:08.773Z
SHA-256 of the archived text
062c788e78f67279f94d992f9a48cf08c27183c4eab9de6592ac4a44a729b773
Stable URL of this page
https://metraipolis.com/documento/dc_5851a03ecee4

How to cite

Tumor-Treating Fields Plus Temozolomide Versus Temozolomide Alone in Newly Diagnosed Glioblastoma: A Systematic Review and Bayesian Meta-Analysis with… — Europe PMC PMID:42352481 — Europe PMC (en), https://europepmc.org/article/MED/42352481 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5851a03ecee4 (Metraipolis archive dc_5851a03ecee4, sha256 062c788e78f67279f94d992f9a48cf08c27183c4eab9de6592ac4a44a729b773)
BibTeX
@misc{dc5851a03ecee4,
  title = {Tumor-Treating Fields Plus Temozolomide Versus Temozolomide Alone in Newly Diagnosed Glioblastoma: A Systematic Review and Bayesian Meta-Analysis with… — Europe PMC PMID:42352481},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42352481},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5851a03ecee4; sha256 062c788e78f67279f94d992f9a48cf08c27183c4eab9de6592ac4a44a729b773},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42352481. Agents can read the archived copy with the MCP tool read_document.